Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Dyrstad 2015 Abstract MiPschool London 2015

From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Activation of epithelial to mesenchymal transition (EMT) regulates stemness and metabolic reprogramming in mammary epithelial cells.

Link:

Dyrstad Sissel E, Roesland GV, Tusubira D, Pettersen IKN, Lorens JB, Tronstad KJ (2015)

Event: MiPschool London 2015

Epithelial to mesenchymal transition (EMT) is a functional and phenotypic shift involving changes in cell morphology and regulatory cascades. Both EMT, as well as its reverse process MET is critical in embryonic development and in pathogenesis, including fibrosis and wound healing, as well as cancer. We hypothesized that metabolic reprogramming is important to fulfill the phenotypic plasticity involved in EMT [1]. Therefore we introduced TWIST, a regulator of EMT, in the immortalized mammary epithelial cells MCF10A.

The Seahorse XFe Exracellular Flux Analyzer (96w) was used to measure the respiratory and glycolytic capacity of the cells. Western blot, qPCR and flow cytometry was used to analyze mitochondrial alterations whereas the xCelligence RTCA Analyzer was used to measure proliferation. We confirmed EMT by changes in morphology, and a panel of markers of EMT (E-cad, N-cad, Vimentin).

Paralleling the EMT induction, we find an increased stem cell profile including decreased proliferation, lowered RNA content (cellular quiescence), as well as upregulation of the stem cell markers CD44, PRXXI, Axl and NOTCH 3. We observed a shift in energy metabolism towards mitochondrial respiration relative to glycolysis during EMT, but in general, the metabolic rates were reduced. Furthermore, there was increase in both mitochondrial DNA content, as well as the mitochondrial membrane potential (ΔΨm). The shift towards oxidative metabolism was associated with distinct changes in the regulation and expression of several enzymes and regulators of glycolysis and mitochondrial respiration. Furthermore, upon analysis of the acetyl-CoA carboxylase (ACC), a multifunctional enzyme complex involved in fatty acid synthesis, we find the ACCA to be downregulated, whereas the ACCB is increasing in TWIST overexpressing cells. ACCA is known to stimulate lipid accumulation in the cytoplasm [2] whereas ACCB is known to control fatty acid oxidation by means of inhibition of carnitine palmitolytransferase I [3], and thereby reduce the fatty acid uptake and oxidation by mitochondria.

In summary, these findings suggest that EMT induces both stemness in MCF10A cells and mediates a metabolic program shift with increased contribution of mitochondrial ATP production relative to glycolysis. Abrogation of the regulation of EMT, metabolism and cell stemness has been linked to tumor initiation and development. This study provides new knowledge on the potentially targetable mechanisms linking cell signaling with metabolism, under the control of TWIST.


O2k-Network Lab: NO Bergen Tronstad KJ


Labels:


Organism: Human  Tissue;cell: Endothelial;epithelial;mesothelial cell, Other cell lines 


Regulation: Fatty acid  Coupling state: LEAK, ROUTINE, ET  Pathway: N, ROX 



Affiliations

Dept Biomedicine, Univ Bergen, Norway. - [email protected]

Figures

MiPschool2015 Drystad Figure1.jpg

Figure 1. EMT leads to a reduction in oxygen consumption rate (OCR) suggesting metabolic alterations.

MiPschool2015 Drystad Table.jpg

Table 1. As EMT is induced there is a shift in mitochondrial related RNA content


References

  1. Nieto MA, (2013) Epithelial plasticity: A common theme in embryonic and cancer cells. Science 342:1234850.
  2. Scott KE, Wheeler FB, Davis AL, Thomas MJ, Ntambi JM, Seals DF, Kridel SJ (2012) Metabolic Regulation of Invadopodia and Invasion by Acetyl-CoA Carboxylase 1 and De novo Lipogenesis. PLoS ONE 7:p.e29761.
  3. Ma L, Murea M, Snipes JA, Marinelarena A, Krüger J, Hicks PJ, Langberg KA, Bostrom MA, Cooke JN, Suzuki D, Babazono T, Uzu T, Tang SC, Mondal AK, Sharma NK, Kobes S, Antinozzi PA, Davis M, Das SK, Rasouli N, Kern PA, Shores NJ, Rudel LL, Blüher M, Stumvoll M, Bowden DW, Maeda S, Parks JS, Kovacs P, Hanson RL, Baier LJ, Elbein SC, Freedman BI (2013) An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects. PLoS ONE 8:p.e56193.